Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Nov 08, 2021 6:49pm
131 Views
Post# 34102484

RE:RE:RE:RE:A lot of odd stuff going on

RE:RE:RE:RE:A lot of odd stuff going onUnfortunately, that is a real risk for tax loss sellers this year. The phase 1a could easily be finishing up around now but if it goes to the last dosage level you should probably be all right.
PWIB123 wrote: If that is the case, I now hope it takes until the end of the year to find out.  I placed an order to sell 21,850 shares today at $3.50 to harvest tax losses and partially offset gains from other investments.  I was only able to sell out around 8,000 shares today, so if the price action stays the same as the last month, it will take 3 days for me to liquidate the shares I'm upside down in.  I'm keeping the rest of my shares and am planning on buying back in after 30 days from my last sale.  Now watch, after holding all this time, some big news will come out and I'll only partially participate after unloading 25% of my position.  Ha!


<< Previous
Bullboard Posts
Next >>